Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platinum-Based Chemotherapy by BRCA Expression in Metastatic Gastric Cancer
NCT03838406Completed
- Sponsor
- Chung-Ang University
- Start
- Aug 2017
- Primary completion
- Dec 2019
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Open-label trial of oxaliplatin in gastric cancer (GC) (2 arms), sponsored by Chung-Ang University. Primary endpoint: Objective Response Rate at 1 year. Started Aug 2017; status: completed.
02
Drugs
oxaliplatin
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT03838406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03838406.